Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Age-Related Macular Degeneration (ARMD)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT03714308
What this trial is testing

Aflibercept Injection Into the Vitreous Body of the Eye: Study to Learn More About Patient Relevant Outcomes, Real World Treatment Patterns and How Well the Treatment Works for Patients Suffering From Abnormal Growth of New Blood Vessels Under the Retina.

Who this might be right for
Macular Degeneration
Bayer 554
Not applicableUnknownNCT02871817
What this trial is testing

A Comparison of the Checkup Vision Assessment System to Standard Vision Assessment Tools

Who this might be right for
Age - Related Macular DegenerationDiabetic RetinopathyMetamorphopsia
Digisight Technologies, Inc. 143
Not applicableEnded earlyNCT03133117
What this trial is testing

Deficits, Adaptation and Cerebral Functional Reorganization of Visual Retinotopic Treatments During Normal and Pathological Aging (Age-related Macular Degeneration and Glaucoma)

Who this might be right for
Macular DegenerationGlaucoma
University Hospital, Grenoble 24
Early research (Phase 1)Study completedNCT01691261
What this trial is testing

Implantation of Retinal Pigment Epithelium in Subjects with Acute Wet Age Related Macular Degeneration

Who this might be right for
Age Related Macular Degeneration
Moorfields Eye Hospital NHS Foundation Trust 9
Large-scale testing (Phase 3)Study completedNCT00305630
What this trial is testing

Neovascular Age Related Macular Degeneration (AMD), Periocular Corticosteroids, and Photodynamic Therapy (PDT)

Who this might be right for
Choroidal NeovascularizationAge-Related Macular Degeneration
Johns Hopkins University 100
Not applicableStudy completedNCT05066685
What this trial is testing

Characteristics of Patients With Neovascular Age-related Macular Degeneration Enrolled in the Brolucizumab Patient Support Services Program

Who this might be right for
Age-related Macular Degeneration (AMD)
Novartis Pharmaceuticals 18,457
Not applicableStudy completedNCT02425501
What this trial is testing

Special Drug Use Investigation of EYLEA for Diabetic Macular Edema

Who this might be right for
Macular Edema
Bayer 646
Not applicableActive Not RecruitingNCT06125977
What this trial is testing

Impact of Non-Exudative Type 1 MNV on AMD Progression

Who this might be right for
Age-Related Macular DegenerationNeovascularization, Choroidal
University of Utah 73
Not applicableUnknownNCT03466177
What this trial is testing

Multimodal Retinal Imaging in the Detection and Follow-up of Alzheimer's Disease

Who this might be right for
Alzheimer DiseaseAlzheimer DementiaMild Cognitive Impairment+4 more
Universitaire Ziekenhuizen KU Leuven 320
Large-scale testing (Phase 3)Study completedNCT05520177
What this trial is testing

A Phase III Study for 601 Versus Ranibizumab in Patients With Vision Loss

Who this might be right for
Branch Retinal Vein Occlusion
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. 351
Not applicableLooking for participantsNCT05976139
What this trial is testing

Micropulsed Laser in Patients With Macular Oedema in Retinal Dystrophies

Who this might be right for
Macular EdemaInherited Retinal DystrophyLaser Retinopathy
Fondazione G.B. Bietti, IRCCS 10
Not applicableLooking for participantsNCT06843499
What this trial is testing

Effectiveness and Cost-Effectiveness Evaluations of AI-Assisted Diagnostic Software (VeriSee) for Ophthalmic Disease Screening

Who this might be right for
Age-Related Macular Degeneration (AMD)Diabetic Retinopathy (DR)
National Taiwan University Hospital 1,000
Very early researchStudy completedNCT03478865
What this trial is testing

Vitamin A Palmitate Supplementation in People With Age-Related Macular Degeneration (and Without Reticular Pseudodrusen) and Delayed Dark Adaptation

Who this might be right for
AMD
National Eye Institute (NEI) 8
Large-scale testing (Phase 3)Study completedNCT00168298
What this trial is testing

The Safety and Efficacy of a New Treatment for Macular Edema Resulting From Retinal Vein Occlusion

Who this might be right for
Macular EdemaRetinal Vein Occlusion
Allergan 668
Early research (Phase 1)Study completedNCT00320775
What this trial is testing

Safety and Tolerability Study of Intravitreal VEGF-Trap Administration in Patients With Neovascular AMD

Who this might be right for
Macular Degeneration
Regeneron Pharmaceuticals 51
Post-approval studies (Phase 4)Study completedNCT01986907
What this trial is testing

Safety and Tolerability of Ranibizumab in Mono/Bilateral Wet Age Related Macular Degeneration (w-AMD) Patients in Eyes With BCVA<2/10 and/or 2nd Affected Eye

Who this might be right for
Wet Age Related Macular Degeneration
Novartis Pharmaceuticals 1,049
Early research (Phase 1)Study completedNCT00500344
What this trial is testing

CAPTAIN:Choroidal Neovascularization Assessment by Pattern Electroretinography

Who this might be right for
Age-related Macular Degeneration
Washington University School of Medicine 17
Testing effectiveness (Phase 2)Study completedNCT00820014
What this trial is testing

Ocular Biodistribution Study for Topically Applied ESBA105

Who this might be right for
Cataract
ESBATech AG 79
Testing effectiveness (Phase 2)Study completedNCT00511706
What this trial is testing

Safety and Efficacy of a New Treatment as Adjunctive Therapy to Anti-vascular Endothelial Growth Factor (Anti-VEGF) Treatment in Patients With Age-Related Macular Degeneration (AMD)

Who this might be right for
Choroidal NeovascularizationAge-Related Maculopathy
Allergan 243
Testing effectiveness (Phase 2)Ended earlyNCT02228304
What this trial is testing

Study of the Intravitreal Implantation of NT-503-3 Encapsulated Cell Technology (ECT) for the Treatment of Recurrent Choroidal Neovascularization (CNV) Secondary to Age-related Macular Degeneration (AMD)

Who this might be right for
Macular Degeneration
Neurotech Pharmaceuticals 42
Next Page